BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10297946)

  • 1. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
    Cirn JT
    Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
    Yesalis CE; Lipson DP; Norwood GJ; Helling DK; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):737-45. PubMed ID: 6381921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capitation payment for pharmacy services: impact on generic substitution.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Fisher WP; Burmeister LF
    Med Care; 1980 Aug; 18(8):816-28. PubMed ID: 6997648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and costs under the Iowa capitation drug program.
    Yesalis CE; Norwood GJ; Lipson DP; Helling DK; Burmeister LF; Fisher WP
    Health Care Financ Rev; 1981 Sep; 3(1):127-36. PubMed ID: 10309472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capitation payment for pharmacy services. II. Impact on costs.
    Yesalis CE; Norwood GJ; Helling DK; Lipson DP; Mahrenholz RJ; Burmeister LF; Jones ME; Fisher WP
    Med Care; 1984 Aug; 22(8):746-54. PubMed ID: 6381922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preimplementation assessment of a capitation reimbursement system using simulation.
    Standridge CR; Fisher WP; Tsai J
    J Med Syst; 1983 Feb; 7(1):43-59. PubMed ID: 6345708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capitation payment for medicaid pharmacy services: impact on non-medicaid prescriptions.
    Lipson DP; Yesalis CE; Kohout FJ; Norwood GJ
    Med Care; 1981 Mar; 19(3):342-53. PubMed ID: 7012466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimbursement by capitation: it's new, controversial, and strengthens incentive.
    Norwood GJ; Yesalis C; Lipson D; Johnson N
    Am Pharm; 1979 Jan; 19(1):37-40. PubMed ID: 364969
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capitation for pharmacy services: rationale, findings, and future plans.
    Lipson DP; Yesalis CE; Norwood GJ
    Med Mark Media; 1980 Oct; 15(10):25-32. PubMed ID: 10249119
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of capitation rates for prescription medication benefits from an insurance perspective.
    Lawson KA
    Benefits Q; 1991; 7(3):52-61. PubMed ID: 10117172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copayment for pharmaceutical services in a Medicaid program.
    Nelson AA; Quick MR
    Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capitation payment for pharmacy services: are we ready?
    Berger BA
    Med Mark Media; 1980 Oct; 15(10):33-6. PubMed ID: 10249120
    [No Abstract]   [Full Text] [Related]  

  • 17. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential impact of prepayment on Medicaid drug costs.
    Yesalls CE; Norwood GJ; Lipson DP
    Contemp Pharm Pract; 1979; 2(2):87-94. PubMed ID: 10297462
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.